128 related articles for article (PubMed ID: 10841950)
1. Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients.
Otsuki T; Sakaguchi H; Tomokuni A; Aikoh T; Matsuki T; Isozaki Y; Hyodoh F; Kawakami Y; Kusaka M; Kita S; Ueki A
Immunol Lett; 2000 May; 72(2):137-43. PubMed ID: 10841950
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.
Otsuki T; Tomokuni A; Sakaguchi H; Aikoh T; Matsuki T; Isozaki Y; Hyodoh F; Ueki H; Kusaka M; Kita S; Ueki A
Clin Exp Immunol; 2000 Feb; 119(2):323-7. PubMed ID: 10632670
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas mRNA is dominantly expressed in cases with silicosis.
Otsuki T; Sakaguchi H; Tomokuni A; Aikoh T; Matsuki T; Kawakami Y; Kusaka M; Ueki H; Kita S; Ueki A
Immunology; 1998 Jun; 94(2):258-62. PubMed ID: 9741350
[TBL] [Abstract][Full Text] [Related]
4. Alterations of Fas and Fas-related molecules in patients with silicosis.
Otsuki T; Miura Y; Nishimura Y; Hyodoh F; Takata A; Kusaka M; Katsuyama H; Tomita M; Ueki A; Kishimoto T
Exp Biol Med (Maywood); 2006 May; 231(5):522-33. PubMed ID: 16636300
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble Fas ligand in patients with silicosis.
Tomokuni A; Otsuki T; Isozaki Y; Kita S; Ueki H; Kusaka M; Kishimoto T; Ueki A
Clin Exp Immunol; 1999 Dec; 118(3):441-4. PubMed ID: 10594565
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cases with silicosis using the parameters related to Fas-mediated apoptosis.
Otsuki T; Ichihara K; Tomokuni A; Sakaguchi H; Aikoh T; Matsuki T; Isozaki Y; Hyodoh F; Kusaka M; Kita S; Ueki A
Int J Mol Med; 1999 Oct; 4(4):407-11. PubMed ID: 10493983
[TBL] [Abstract][Full Text] [Related]
7. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours.
Tomokuni A; Aikoh T; Matsuki T; Isozaki Y; Otsuki T; Kita S; Ueki H; Kusaka M; Kishimoto T; Ueki A
Clin Exp Immunol; 1997 Nov; 110(2):303-9. PubMed ID: 9367417
[TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
[TBL] [Abstract][Full Text] [Related]
9. [Dysregulation of Fas and related molecules in silicosis patients].
Takata-Tomokuni A; Miura Y; Hyodoh F; Katsuyama H; Ueki A; Otsuki T
Nihon Eiseigaku Zasshi; 2005 Jan; 60(1):30-7. PubMed ID: 15773295
[TBL] [Abstract][Full Text] [Related]
10. Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases.
Christensson M; Pettersson E; Eneslätt K; Christensson B; Bratt J; Rantapää-Dahlqvist S; Sundqvist KG
J Clin Immunol; 2002 Jul; 22(4):220-7. PubMed ID: 12148596
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fas/Apo-1 splicing variants and apoptosis.
Cascino I; Papoff G; Eramo A; Ruberti G
Front Biosci; 1996 Jan; 1():d12-8. PubMed ID: 9159204
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
Liu C; Cheng J; Mountz JD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):957-63. PubMed ID: 7575433
[TBL] [Abstract][Full Text] [Related]
13. [Fas-Fas ligand system in silicosis patients].
Ueki A
Nihon Eiseigaku Zasshi; 2000 Jul; 55(2):474-80. PubMed ID: 10981180
[TBL] [Abstract][Full Text] [Related]
14. Fas/FasL pathway-mediated alveolar macrophage apoptosis involved in human silicosis.
Yao SQ; Rojanasakul LW; Chen ZY; Xu YJ; Bai YP; Chen G; Zhang XY; Zhang CM; Yu YQ; Shen FH; Yuan JX; Chen J; He QC
Apoptosis; 2011 Dec; 16(12):1195-204. PubMed ID: 21910009
[TBL] [Abstract][Full Text] [Related]
15. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons.
Hosaka N; Oyaizu N; Kaplan MH; Yagita H; Pahwa S
J Infect Dis; 1998 Oct; 178(4):1030-9. PubMed ID: 9806031
[TBL] [Abstract][Full Text] [Related]
16. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
Hamzaoui A; Ammar J; Graïri H; Hamzaoui K
Mediators Inflamm; 2003 Aug; 12(4):209-14. PubMed ID: 14514471
[TBL] [Abstract][Full Text] [Related]
17. Fas-Fas ligand system in the peripheral blood of patients with renal diseases.
Sato M; Konuma T; Yanagisawa N; Haizuka H; Asakura H; Nakashima Y
Nephron; 2000 Jun; 85(2):107-13. PubMed ID: 10867515
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis.
Sturlese E; Salmeri FM; Retto G; Pizzo A; De Dominici R; Ardita FV; Borrielli I; Licata N; Laganà AS; Sofo V
J Reprod Immunol; 2011 Dec; 92(1-2):74-81. PubMed ID: 21978769
[TBL] [Abstract][Full Text] [Related]
19. Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis.
Takata-Tomokuni A; Ueki A; Shiwa M; Isozaki Y; Hatayama T; Katsuyama H; Hyodoh F; Fujimoto W; Ueki H; Kusaka M; Arikuni H; Otsuki T
Immunology; 2005 Sep; 116(1):21-9. PubMed ID: 16108814
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies detectable in the sera of silicosis patients. The relationship between the anti-topoisomerase I antibody response and HLA-DQB1*0402 allele in Japanese silicosis patients.
Ueki A; Isozaki Y; Tomokuni A; Tanaka S; Otsuki T; Kishimoto T; Kusaka M; Aikoh T; Sakaguchi H; Hydoh F
Sci Total Environ; 2001 Apr; 270(1-3):141-8. PubMed ID: 11327387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
